Chugai Pharmaceutical Co., Ltd.
¥6,822+¥169 (+2.54%)
Chugai Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 36.24% below the high.
JPX · 4483.T · JPY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · JPY. Historical prices are not a forecast.
JMDC Inc.’s quoted price sits in the upper half of its reported 52-week range, 25.45% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
JMDC Inc.’s forward annual dividend is ¥18 per share, paid annual. The forward yield is 0.49% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
JMDC Inc.’s next earnings report is currently expected on Nov 5, 2026, with estimated earnings per share of ¥26. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow JMDC Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
JMDC Inc. is a Japanese corporation primarily focused on delivering analytical and statistical services for the medical sector. Its operations are structured across three principal divisions: Healthcare-Big Data, Telemedicine, and Dispensing Pharmacy Support. Within the Healthcare-Big Data segment, the company provides extensive big data solutions tailored for both the medical and life insurance industries. It also offers crucial support services to health insurance associations and local government health programs, develops a robust health data platform, and aids medical institutions. The Telemedicine division facilitates remote medical imaging interpretation through specialized matching services and ASP systems. Concurrently, its Dispensing Pharmacy Support segment develops and markets bespoke business management software specifically designed for dispensing pharmacies. JMDC serves a broad spectrum of clients, including health insurance providers, pharmaceutical manufacturers, life and general insurance companies, and research organizations. The company, established in 2002, maintains its corporate headquarters in Tokyo, Japan.
Latest available per-share figures in JPY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:48 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| May 7, 2025 |
| ¥52+46.59% vs estimate |
| ¥11.12B-14.53% vs estimate |
| Q3 2024 | Feb 5, 2025 | ¥26-27.36% vs estimate | ¥11.41B-3.68% vs estimate |
|---|
| Q2 2024 | Nov 5, 2024 | ¥22+42.57% vs estimate | ¥10.78B+5.83% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
¥6,822+¥169 (+2.54%)
Chugai Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 36.24% below the high.
¥1,841-¥4 (-0.22%)
M3, Inc.’s quoted price sits in the lower half of its reported 52-week range, 32.98% below the high.
¥2,588+¥79 (+3.15%)
SMS Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 6.03% below the high.
¥2,386+¥33 (+1.4%)
Medley, Inc.’s quoted price sits in the upper half of its reported 52-week range, 21.51% below the high.
¥1,490+¥66 (+4.63%)
Value HR Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 21.54% below the high.
¥2,294+¥12 (+0.53%)
Kusurinomadoguchi, Inc.’s quoted price sits in the lower half of its reported 52-week range, 34.46% below the high.
¥856+¥8 (+0.94%)
FINDEX Inc.’s quoted price sits in the lower half of its reported 52-week range, 15.33% below the high.
¥700+¥2 (+0.29%)
Data Horizon Corporation’s quoted price sits in the upper half of its reported 52-week range, 6.29% below the high.